Corporate Ads

IQSTEL, Inc. (Stock Symbol: IQSTD) On Track Towards $1 Billion in Revenue by 2027.

$BEAT Clinical Endpoints Successfully Met in Pivotal Study, Plus FDA Clearance for At-Home, High-Fidelity Heart Monitoring System.

$IQSTD Also Signs MOU to Acquire Majority Stake in Fintech Leader GlobeTopper, Plus $1 Million Subsidiary Sale with Stock Dividend to Shareholders. iQSTEL, Inc. (Stock Symbol: IQSTD)

$NRXP Set Up for $300 Million in Milestones on Tiered Double-Digit Royalties. NRx Pharmaceuticals, Inc. (Stock Symbol: NRXP)

$300 Million Set up in Milestones for $NRXP on Tiered Double-Digit Royalties

$BEAT Forms Strategic Collaboration with AccurKardia for Ambulatory ECG Recording and Analysis to Advance Cardiac Monitoring Care. HeartBeam, Inc. (Stock Symbol: BEAT)

NRx Pharmaceuticals, Inc. (Stock Symbol: NRXP) $NRXP Set Up for $300 Million in Milestones on Tiered Double-Digit Royalties

iQSTEL, Inc. (Stock Symbol: IQST) $IQST Also Signs MOU to Acquire Majority Stake in Fintech Leader GlobeTopper, Plus $1 Million Subsidiary Sale with Stock Dividend to Shareholders

$ASTI is a Developer of Innovative, High-Performance, Flexible Thin-Film Solar Panel Technology used in Space and Industrial Applications.

$ASTI has Multiple Strategic Partners in the Space Market, Including a Major Defense Contractor, Multiple Deployable Technology Companies and a Satellite Company.